Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Local Sales Bans on Flavored Tobacco Products in California Cut Use
MONDAY, May 29, 2023 -- Banning flavored tobacco products leads to fewer people using them, according to a new California study that found lower usage in areas...
When Arthritis Strikes, Keep Moving
MONDAY, May 29, 2023 -- Your achy joints may suggest that you take it easy. Don’t listen to them, experts say. If it hurts when you get up from a chair...
Stress Across the Life Span Could Worsen MS
MONDAY, May 29, 2023 -- Multiple sclerosis (MS) is a chronic disease that attacks the central nervous system and leaves patients suffering from a host of...
With Training, Soccer Headers Might Be Safe for Teen Players
MONDAY, May 29, 2023 -- Limited "heading" of a soccer ball in youth sports may not cause irreversible harm, as long as players are properly trained, a new...
Grilling Plant-Based Burgers This Memorial Day? Safe Cooking Temperatures May Change
SUNDAY, May 28, 2023 -- The last thing you want to invite to your Memorial Day cookout is foodborne illness. An expert from Virginia Tech offers some...
FDA Approves Inpefa (sotagliflozin) for the Treatment of Heart Failure
THE WOODLANDS, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration...
Bariatric Surgery Tied to Less Medication Use Over 15 or More Years
FRIDAY, May 26, 2023 -- Patients undergoing bariatric surgery for obesity use fewer lipid-lowering, cardiovascular, and antidiabetic medications over the long...
Multivitamin Shows Memory Benefits in Older Adults
FRIDAY, May 26, 2023 -- Daily multivitamin supplementation improves memory in older adults compared with placebo, according to a study published online May 24...
Elon Musk's Neuralink Says Brain-to-Computer Interface Has FDA Approval for Clinical Trial
FRIDAY, May 26, 2023 -- It may sound like the stuff of science fiction, but Elon Musk's company Neuralink announced Thursday that the U.S. Food and Drug...
Takeda and Hutchmed Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
OSAKA, Japan, CAMBRIDGE, Massachusetts, HONG KONG, SHANGHAI &, FLORHAM PARK, New Jersey, Friday May 26, 2023 – Takeda (TSE:4502/NYSE:TAK) and...
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
SAN CARLOS, Calif., May 26, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing...
Social Vulnerability Tied to Higher Assault-Related Firearm Death Rates for Youth
FRIDAY, May 26, 2023 -- States with restrictive gun laws have lower rates of assault-related firearm deaths among youths, but youths from socially vulnerable...
Sargassum Seaweed Can Be Hazardous to Health
FRIDAY, May 26, 2023 -- A 5,000-mile floating mass of sargassum seaweed has begun washing up on Florida's beaches. It can be low risk in some instances, but it...
FDA Approves Paxlovid (nirmatrelvir tablets and ritonavir tablets) for Adult Patients at High Risk of Progression to Severe COVID-19
NEW YORK--(BUSINESS WIRE) May 25, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved Paxlovid&trade...
FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira
JERSEY CITY, N.J.--(BUSINESS WIRE) May 24, 2023 --Celltrion USA today announced that the U.S. Food and Drug Administration (FDA) has approved Yuflyma®...
FDA Approves Xacduro (sulbactam and durlobactam) for the Treatment of Serious Infections Caused by Acinetobacter
WALTHAM, Mass.--(BUSINESS WIRE)--May 23, 2023-- Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that the U.S...
Phathom Pharmaceuticals Resubmits Vonoprazan Erosive GERD New Drug Application to FDA
FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and...
FDA Approves Brixadi (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder
Plymouth Meeting, Pa. -- May 23, 2023—Braeburn announces that the U.S. Food and Drug Administration (FDA) has approved Brixadi (buprenorphine)...
bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events
SOMERVILLE, Mass.--(BUSINESS WIRE)--Apr. 24, 2023-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the submission of its Biologics License Application (BLA)...
Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)-- April 21, 2023 -- Daiichi Sankyo (TSE: 4568) today announced that the U.S. Food and Drug Administration...
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer
MELBOURNE, Australia, May 29, 2023. Amplia Therapeutics Limited ("Amplia" or the "Company") is pleased to announce new data showing the efficacy of its...
CHOP Researchers Show that IgA Fine Tunes the Body's Interactions with Microbes
PHILADELPHIA, May 26, 2023. IgA deficiency is the most common primary immune deficiency worldwide, but its presentation has puzzled physcians and researchers...
Updated Linvoseltamab (BCMAxCD3) Data from Pivotal Trial Demonstrates Early, Deep and Durable Responses in Patients with Heavily Pre-treated Multiple Myeloma
TARRYTOWN, N.Y., May 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced updated data from two Phase 2 expansion dose...
Fianlimab (LAG-3 inhibitor) Combined with Libtayo® (cemiplimab) Shows Clinically Meaningful and Durable Tumor Responses Across Key Advanced Melanoma Patient Populations
TARRYTOWN, N.Y., May 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive data from three independent cohorts...
Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
RARITAN, NJ, May 25, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that all three prospective indications for...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.